Life Science Companies: Managing a Turbulent Future
Event: WorkshopStart date: 25 Apr 2007 10:00
End date: 27 Apr 2007 14:30
Speaker(s):
Christopher Paul Milne, Assistant Director of the Tufts Center for the Study of Drug Development
Graham Hunt, Associate Director, Development Informatics, Pfizer Global Research and Development, Pfizer UK
Alastair Kent, Director, Genetic Interest Group (GIG) - the UK alliance of charities and support groups for people affected by genetic disorders.
Organised by: Innogen
Venue: The Scotsman Hotel, Edinburgh.
Innogen are launching their Executive Development Programme with an exciting 3-day course covering Innovation Processes; Policy Regulation and Governance; and Stakeholder Powers and Governance.
Innovation Processes
- Managing interactions
- Changing relationships between discovery and development
- Translation to public sector markets and development for commercial markets
- Changing relationships between small and large firms
- Managing new types of product
Regulation and Governance
- Regulatory developments and global governance of life sciences
- Risk management
- New kinds of product create new regulatory needs
- Intellectual property
Stakeholder Influences
- Changing nature of markets for life science products (public and commercial, developed and developing world)
- New ranges of stakeholders to be considered
- How to manage different stakeholder responses (without their different interests or values)
Further details:
Please contact Julie Hamilton for further details or to request a brochure.
Course Sponsor
PRIME - Policies for Research and Innovation in the Move towards the European Research Area
Prime is a Network of Excellence supported by the EU's 6th Framework Programme. Over 200 researchers from 40 institutes are involved with the aim of integrating and spreading of excellence, and initiating joint research actions.
back
